ÂÜÀòÂÒÂ×

Jason Cole is an experienced executive in the biotechnology and life sciences sectors, currently serving as the Chief Executive Officer and Chair of the Board of Directors at SalioGen Therapeutics, where efforts focus on innovative gene coding technologies for genetic medicine. With a strong background in strategic development, corporate governance, and legal affairs, Jason has held significant leadership positions including Chief Strategy and Financial Officer and Chief Operating & Legal Officer at bluebird bio, where pivotal contributions were made to gene therapy advancements. Additionally, Jason has been a member of the Executive Committee of the Board of Directors for MassBio since 2017, providing vital insights on public policy and economic development. Prior roles also include executive responsibilities at Zalicus Inc. and CombinatoRx, along with legal practice at Ropes & Gray LLP. Jason holds a JD from Columbia Law School and a BA in Government from Dartmouth College.